首页> 外文期刊>ChronoPhysiology and Therapy >Formulation and optimization of chronomodulated press-coated tablet of carvedilol by Box–Behnken statistical design
【24h】

Formulation and optimization of chronomodulated press-coated tablet of carvedilol by Box–Behnken statistical design

机译:Box–Behnken统计设计制定和优化卡维地洛调压包衣片剂的配方

获取原文
           

摘要

Objective: The primary objective of the present investigation was to formulate and optimize chronomodulated press-coated tablets to deliver the antihypertensive carvedilol at an effective quantity predawn, when a blood pressure spike is typically observed in most hypertensive patients. Experimental work: Preformulation studies and drug excipient compatibility studies were carried out for carvedilol and excipients. Core tablets (6 mm) containing carvedilol and 10-mm press-coated tablets were prepared by direct compression. The Box–Behnken experimental design was applied to these press-coated tablets (F1–F15 formula) with differing concentrations of rate-controlling polymers. Hydroxypropyl methyl cellulose K4M, ethyl cellulose, and K-carrageenan were used as rate-controlling polymers in the outer layer. These tablets were subjected to various precompression and postcompression tests. The optimized batch was derived both by statistically (using desirability function) and graphically (using Design Expert? 8; Stat-Ease Inc). Tablets formulated using the optimized formulas were then evaluated for lag time and in vitro dissolution. Results and discussion: Results of preformulation studies were satisfactory. No interaction was observed between carvedilol and excipients by ultraviolet, Fourier transform infrared spectroscopy, and dynamic light scattering analysis. The results of precompression studies and postcompression studies were within limits. The varying lag time and percent cumulative carvedilol release after 8 h was optimized to obtain a formulation that offered a release profile with 6 h lag time, followed by complete carvedilol release after 8 h. The results showed no significant bias between predicted response and actual response for the optimized formula. Conclusion: Bedtime dosing of chronomodulated press-coated tablets may offer a promising alternative to control early morning hypertensive increase.
机译:目的:本研究的主要目的是配制和优化计时调压片剂,以在大多数高血压患者中通常观察到血压升高的黎明前以有效量递送降压卡维地洛。实验工作:对卡维地洛和赋形剂进行了制剂前研究和药物赋形剂相容性研究。通过直接压制制备含有卡维地洛的核心片(6mm)和10mm压制片。 Box-Behnken实验设计应用于具有不同浓度的控速聚合物的这些压制片剂(F1-F15配方)。羟丙基甲基纤维素K4M,乙基纤维素和K-角叉菜胶用作外层中的速率控制聚合物。这些片剂经历了各种压缩前和压缩后测试。通过统计(使用合意函数)和图形化(使用Design Expert ? 8; Stat-Ease Inc)得出优化的批次。然后评估使用优化配方配制的片剂的滞后时间和体外溶出度。结果与讨论:制剂研究的结果令人满意。通过紫外,傅立叶变换红外光谱和动态光散射分析未观察到卡维地洛与赋形剂之间的相互作用。压缩前研究和压缩后研究的结果均在限制范围内。优化了8小时后变化的滞后时间和卡维地洛的累积释放百分比,以得到在滞后时间为6小时时具有释放特性的制剂,然后在8小时后完全释放卡维地洛。结果表明,优化配方在预测响应和实际响应之间没有显着偏差。结论:计时调制的压力包衣片的就寝时间给药可能为控制晨起的高血压增加提供有希望的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号